Reckitt Benckiser Group Plc (LON:RB) insider Christopher Sinclair purchased 1,076 shares of Reckitt Benckiser Group stock in a transaction dated Thursday, May 23rd. The shares were acquired at an average cost of GBX 6,375 ($83.30) per share, for a total transaction of £68,595 ($89,631.52).

Reckitt Benckiser Group stock opened at GBX 6,413 ($83.80) on Friday. Reckitt Benckiser Group Plc has a 1-year low of GBX 5,559 ($72.64) and a 1-year high of GBX 7,174 ($93.74). The company has a debt-to-equity ratio of 80.49, a quick ratio of 0.47 and a current ratio of 0.65. The firm has a market capitalization of $45.40 billion and a price-to-earnings ratio of 21.04.

Several analysts have recently issued reports on the company. Deutsche Bank set a GBX 8,000 ($104.53) price objective on Reckitt Benckiser Group and gave the company a “buy” rating in a research note on Thursday, April 11th. Barclays started coverage on Reckitt Benckiser Group in a research report on Tuesday, March 26th. They issued an “overweight” rating and a GBX 7,500 ($98.00) price target on the stock. Berenberg Bank increased their price target on Reckitt Benckiser Group from GBX 7,450 ($97.35) to GBX 7,550 ($98.65) and gave the company a “buy” rating in a research report on Tuesday, February 26th. UBS Group set a GBX 6,300 ($82.32) price target on Reckitt Benckiser Group and gave the company a “neutral” rating in a research report on Monday, February 25th. Finally, JPMorgan Chase & Co. set a GBX 9,000 ($117.60) price target on Reckitt Benckiser Group and gave the company a “buy” rating in a research report on Monday, February 25th. Three analysts have rated the stock with a sell rating, four have given a hold rating and twelve have issued a buy rating to the company’s stock. Reckitt Benckiser Group presently has an average rating of “Hold” and a consensus price target of GBX 7,117.78 ($93.01).

ILLEGAL ACTIVITY NOTICE: “Christopher Sinclair Purchases 1,076 Shares of Reckitt Benckiser Group Plc (RB) Stock” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark legislation. The original version of this report can be read at https://www.watchlistnews.com/christopher-sinclair-purchases-1076-shares-of-reckitt-benckiser-group-plc-rb-stock/3021402.html.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Story: What is the 52-week high/low?

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.